Page last updated: 2024-10-29

avapro and Nerve Degeneration

avapro has been researched along with Nerve Degeneration in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, WJ1
Funk, A1
Herdegen, T1
Unger, T1
Culman, J1

Other Studies

1 other study available for avapro and Nerve Degeneration

ArticleYear
Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats.
    Stroke, 1999, Volume: 30, Issue:11

    Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Apoptosis; Arterial Occlusive Disea

1999